首页 正文

SOT201: cis-acting PD-1/IL-15 mutein-based immunocytokine under investigational study in solid tumors

{{output}}
Introduction: The systemic administration of cytokines is constrained by their pleiotropic activity, dose-dependent toxicities, and short serum half-life, limiting their therapeutic window in cancer treatment. To overcome these c... ...